Investors

Overview

Ra Pharma® is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system.

Stock Quote

  

Copyright West LLC. Minimum 15 minutes delayed.

Stock Chart

Recent News
Ra Pharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of Zilucoplan for IMNM
Read More
Upcoming Events
More events are coming soon.

Contact Us

Ra Pharmaceuticals, Inc.
87 Cambridgepark Drive
Cambridge, MA 02140
Phone: (617) 401-4060
Fax: (617) 401-4061

info@rapharma.com